PHARMACY

SteinCares will handle all regulatory filings, registrations and commercialization of Ranibizumab in Latin America, while Lupin will be responsible for manufacturing the same.

The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

Varenicline tablets are indicated for use as an aid to smoking cessation treatment.

The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.

The highly absorbable, gluten-free formula contains MK-4 and MK-7.

The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development and other efforts.

Clophosphamide has been approved for certain kinds of cancer.

The Duke Specialty Pharmacy expansion is designed to better support patients through lower costs, broader treatment options and enhanced medication management.